Showing results (311-320 of 390) with videos related to
Sort By:
Pageof 39
Brain Research|September 12, 1998
Striking changes in anxiety in Huntington's disease transgenic miceS E File, A Mahal, L Mangiarini, et al.Pharmacology, Biochemistry, and Behavior|August 31, 2001
Different treatment regimens and the development of tolerance to nicotine's anxiogenic effectsE E Irvine, S Cheeta, M Marshall, et al.Psychopharmacology|June 19, 2004
Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?Rachel F Genn, S Tucci, S Parikh, et al.European Journal of Pharmacology|November 3, 1994
5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectivelyN Andrews, S Hogg, L E Gonzalez, et al.Behavioural Pharmacology|July 3, 2003
Do different mechanisms underlie two anxiogenic effects of systemic nicotine?S Tucci, R F Genn, E Marco, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1994
Receptor binding in Japanese quail selected for long or short tonic immobilityS Hogg, S Paterson, A D Mills, et al.International Clinical Psychopharmacology|November 1, 1992
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoatesS McLaren, J C Cookson, T SilverstoneThe British Journal of Psychiatry : the Journal of Mental Science|March 1, 1982
Plasma prolactin and growth hormone levels in manic patients treated with pimozideJ C Cookson, T Silverstone, L ReesPsychopharmacology|January 1, 1980
The effect of small and moderate doses of d-amphetamine on hunger, mood, and arousal in manS Jain, M Kyriakides, T Silverstone, et al.International Clinical Psychopharmacology|April 1, 1988
Cortisol, prolactin and growth hormone levels with clinical ratings in manic patients treated with verapamilT G Dinan, T Silverstone, J C CooksonPageof 39